Myocardial Revascularization by Left Ventricular Assisted Beating Heart Is Associated With Reduced Systemic Inflammatory Response

Annals of Thoracic Surgery

Volumn 87, Issue 1, 2009, Pages 46-52

  Stassano, Paolo ^a   Di Tommaso, Luigi ^a   Monaco, Mario ^a   Iesu, Severino ^e   Brando, Giancarlo ^c   Buonpane, Salvatore ^b   Ambrosio, Giuseppe ^d   Di Benedetto, Giuseppe ^e   Pepino, Paolo ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Istituto Clinico Pineta Grande   (Italy)

^c ItalyCardiac Anaesthesia   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e S Giovanni di Dio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ELASTASE; HEPARIN; POLYMORPHONUCLEAR ELASTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSISTIVE TECHNOLOGY DEVICE; CONTROLLED STUDY; DEMOGRAPHY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART BEAT; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INOTROPISM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; CYTOKINES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57649240835     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.07.098     Document Type: Article

References (30)

1. Raja S.G., and Berg G.A. Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence. J Card Surg 22 (2007) 445-455
2. Puskas J.D., Edwards F.H., Pappas P.A., et al. Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. Ann Thorac Surg 84 (2007) 1447-1456
3. Lattouf O.M., Puskas J.D., Thourani V.H., Noora J., Kilgo P.D., and Guyton R.A. Does the number of grafts influence surgeon choice and patient benefit of off-pump over conventional on-pump coronary artery revascularization in multivessel coronary artery disease?. Ann Thorac Surg 84 (2007) 1485-1495
4. Edgerton J.R., Dewey T.M., Magee M.J., et al. Conversion in off-pump coronary artery bypass grafting: an analysis of predictors and outcomes. Ann Thorac Surg 76 (2003) 1138-1143
5. Fromes Y., Gaillard D., Ponzio O., et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22 (2002) 527-533
6. Mazzei V., Nasso G., Salamone G., Castorino F., Tommasini A., and Anselmi A. Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation 116 (2007) 1761-1767
7. Pepino P., Oliviero P., Petteruti F., Di Tommaso L., Monaco M., and Stassano P. Left heart pump-assisted beating heart coronary surgery in the high risk patients. Asian Cardiovasc Thorac Ann 16 (2008) 159-161
8. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. Circulation 110 (2004) 340-347
9. Frering B., Philip I., Dehoux M., Rolland C., Langlois G.M., and Desmont J.M. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108 (1994) 636-641
10. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 280 (2001) H2649-H2657
11. Zahler S., Massoudy P., Hartl H., Hähnel C., Meisner H., and Becker B.F. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 41 (1999) 722-730
12. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 279 (1998) 1477-1482
13. Cameron D. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. J Cardiovasc Pharmacol 27 Suppl 1 (1996) 1-5
14. Matata B.M., and Galiñanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg 120 (2000) 1-11
15. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
16. Ferrari R. Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res 37 (1998) 554-559
17. Lindholm L., Westerberg M., Bengtsson A., Ekroth R., Jense E., and Jeppsson A. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Ann Thorac Surg 78 (2004) 2131-2138
18. Qing M., Vazquez-Jimenez J.F., Klosterhalfen B., et al. Influence of temperature during cardiopulmonary bypass on leukocytes activation, cytokine balance, and postoperative organ damage. Shock 15 (2001) 372-377
19. Curello S., Ceconi C., de Giuli F., et al. Oxidative stress during reperfusion of human hearts: potential sources of oxygen free radicals. Cardiovasc Res 29 (1995) 118-125
20. Semb A.G., Forsdhal K., and Vaage J. Granulocyte and eicosanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery. Eur J Cardiothorac Surg 4 (1990) 543-548
21. El Habbal M.H., Carter E., Smith L.J., Elliot M.J., and Strobel S. Neutrophil activation in paediatric extracorporeal circuits: effects of circulation and temperature variation. Cardiovasc Res 29 (1995) 102-107
22. Stahl R.F., Fisher C.A., and Kucich U. Effects of simulated extracorporeal circulation on human leucocyte elastase release, superoxide generation, and procoagulant activity. J Thorac Cardiovasc Surg 101 (1991) 230-239
23. Milei J., Forcada P., Fraga C.G., et al. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res 73 (2007) 710-719
24. Abdel-Rahman U., Özaslan F., Risteski P.S., et al. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit?. Ann Thorac Surg 80 (2005) 238-244
25. Butler J., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
26. Galiñanes M., Watson C., Trivedi U., Chambers D.J., Young C.P., and Venn G.E. Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation 94 Suppl (1996) II364-II369
27. Gadek J.E. Adverse effects of neutrophils on the lung. Am J Med 92 Suppl (1992) 27-31
28. Kishima H., Takeda S., Miyoshi S., et al. Microvascular permeability of the no-heart beating rabbit lung after warm ischemia and reperfusion: role of neutrophil elastase. Ann Thorac Surg 65 (1998) 913-918
29. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
30. Yamazaki T., Ooshima H., Usui A., Watanabe T., and Yasuura K. Protective effects of ONO-5046·Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 68 (1999) 2141-2146